Bionano Genomics
BNGO
34 hedge funds and large institutions have $802K invested in Bionano Genomics in 2026 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 2 reducing their positions, and 6 closing their positions.
450% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 2
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
6% more funds holding
Funds holding: 32 → 34 (+2)
1.67% less ownership
Funds ownership: 7.85% → 6.18% (-1.7%)
21% less capital invested
Capital invested by funds: $1.02M → $802K (-$217K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Carret Asset Management
New York
|
+$66.3K |
| 2 |
Jane Street
New York
|
+$43.1K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$19.6K |
| 4 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$17.2K |
| 5 |
HF
HRT Financial
New York
|
+$14.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$245K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$93.4K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$21.1K |
| 4 |
VF
Virtu Financial
New York
|
-$16K |
| 5 |
Vanguard Global Advisers
Malvern,
Pennsylvania
|
-$202 |
BNGO Hedge Fund Activity: Q2 2026 in Review
34 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q2 2026, worth a combined $802K — down 21% from $1.02M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new BNGO positions and 6 closed out — a net gain of 2 holders — while 11 added to existing stakes and 2 trimmed.
The largest buyer was Carret Asset Management, adding an estimated $66.3K. The largest seller was GSA Capital Partners, cutting an estimated $245K.
- 34 institutional investors held Bionano Genomics (BNGO) as of Q2 2026, up from 32 in Q1 2026.
- Funds reported $802K of Bionano Genomics stock for Q2 2026, down 21% quarter-over-quarter.
- 8 funds opened new Bionano Genomics positions in Q2 2026 and 6 closed out, a net change of +2 holders.
- The largest Bionano Genomics buyer in Q2 2026 was Carret Asset Management, an estimated $66.3K added.
- The largest Bionano Genomics seller in Q2 2026 was GSA Capital Partners, an estimated $245K sold.
Based on aggregated 13F filings for Q2 2026.